Immuno-Non-reactive Serumis immunologically non-reactive to various antigens. It is a negative matrix suitable for various immunological applications where the presence of antigens could interfere with experimental outcomes.
HBV Negative Serum is immunologically non-reactive to both HBV antigens and antibodies. It's a negative matrix suitable for diagnostic applications where the presence of HBV antigens or antibody could interfere with the results.
The recombinant Influenza A virus subtype H5N1 Controls are high-quality, reliable tools for research and diagnostic applications.
StorageCondition: <= -70°C Storage
Storage Condition: 2-8°C for short term (3-12 months), -20ºC for long term (> 1 year)
Shipping Condition: Blue Ice.
Shelf Life: Five years from the date of receipt under proper storage condition.
Anchor Molecular offers a comprehensive collection of over 50 commonly observed RNA fusions, organized into eight multiplexed panels optimized for PCR- and NGS-based detection workflows. Each panel contains fusion RNAs at equal copy numbers, ensuring consistent and reliable performance across targets. Designed as a single, consistent, and flexible control source, Anchor Molecular’s Multiplexed RNA Fusion Panels help molecular labs, kit developers, and oncology researchers save time, reduce costs, and streamline regulatory validation.
Panels 6 and 7 include fusions frequently associated with hematologic cancers.
Panels 1, 2, 3, 4, 5, and 8 feature five to seven multiplexed fusions commonly found in solid tumors.
For broader applications, the Multiplexed RNA Fusion Mix v2 combines all solid tumor fusions into a single, convenient panel.
All panels are available as purified RNA in buffer or in FFPE format, supporting a wide range of research and diagnostic applications. For detailed information of each RNA fusion in each panel, here is the link.
We also offer individual RNA fusion controls and BCR-ABL1 panels, available under separate product categories.
For a free sample or to inquire about custom RNA fusions in human plasma or other formats, please contact us at info@anchormolecular.com or +1 925-400-9986 for quote.
cfDNA contains Trisomy 13, 18 and 21 gDNA mixed with female gDNA at 10% spiked in DNA-depleted human plasma. They are used for counting-based assay, such as Revvity’s Vanadis®.
AM Normal cfDNA-1: gDNA is nucleosomally fragmented from a popular normal male cell line
AM Normal cfDNA-2: gDNA is nucleosomally fragmented from normal female cell line
AM Normal cfDNA-3: gDNA is nucleosomally fragmented from pooled normal peripheral blood mononuclear cells (PBMC) from fresh blood
Please view "Description" tab below for product detail.
AM Normal cfDNA-1: DNA is extracted and fragmented from a popular normal male cell line
AM Normal cfDNA-2: DNA is extracted and fragmented from normal female cell line
AM Normal cfDNA-3: DNA is extracted and fragmented from pooled normal peripheral blood mononuclear cells (PBMC) from fresh blood
AM Normal cfDNA-1: DNA is extracted and fragmented from a popular normal male cell line
AM Normal cfDNA-2: DNA is extracted and fragmented from normal female cell line
AM Normal cfDNA-3: DNA is extracted and fragmented from pooled normal peripheral blood mononuclear cells (PBMC) from fresh blood
AM Normal cfDNA-1: DNA is extracted and fragmented from a popular normal male cell line
AM Normal cfDNA-2: DNA is extracted and fragmented from normal female cell line
AM Normal cfDNA-3: DNA is extracted and fragmented from pooled normal peripheral blood mononuclear cells (PBMC) from fresh blood
AM Normal cfDNA-1: DNA is extracted and fragmented from a popular normal male cell line
AM Normal cfDNA-2: DNA is extracted and fragmented from normal female cell line
AM Normal cfDNA-3: DNA is extracted and fragmented from pooled normal peripheral blood mononuclear cells (PBMC) from fresh blood
The POLE-POLD1 Mutation Controls contain formalin-fixed, paraffin-embedded (FFPE) slices with embedded cellular DNA carrying POLE mutations on Exon 9 (P286R), Exon 11 (F367S), Exon 13 (V411L, c.1231 G>C ) and Exon 14 (S459F ) and a POLD1 mutation on Exon 12 (S478N). All variants are present at an approximate 5% allele frequency.